Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline rich 13 pseudogene 4 (PRR13P4) is a human pseudogene listed under NCBI Gene ID 100288008 and HGNC ID 50617[1][3][7]. As a pseudogene, PRR13P4 does not encode a functional protein and is therefore not considered a classical therapeutic target. It has no established physiological function, molecular interactions, or disease associations. Pseudogenes such as PRR13P4 are occasionally studied for their potential regulatory roles in gene expression, but there is currently no evidence establishing PRR13P4 as biologically or clinically relevant in drug targeting or disease processes[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline rich 13 pseudogene 4 (PRR13P4).